Psyence Biomedical Ltd.
PBM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001985062
No open-market purchases or sales by Psyence Biomedical Ltd. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $1.24M in total; no superinvestor holds it.
Other share classesPBMWW
Q2 2026 vs. Q1 2026
How the institutions holding Psyence Biomedical Ltd. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 2 | 9 | +7 |
| Shares | 151.3K | 368.6K | +217.3K (+143.6%) |
| Value | $575.0K | $1.24M | +$665.0K (+115.7%) |
New holders (7)
Institutions that held Psyence Biomedical Ltd. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| AdvisorShares Investments LLC | 122,184 | $373.9K | 0.05% |
| Morgan Stanley | 37,804 | $115.7K | 0.00% |
| Jane Street Group, LLC | 30,431 | $93.1K | 0.00% |
| XTX Topco Ltd | 15,094 | $46.2K | 0.00% |
| Citadel Advisors LLC | 11,693 | $35.8K | 0.00% |
| UBS Group AG | 60 | $184 | 0.00% |
| Caitlin John, LLC | 35 | $107 | 0.00% |
Sold out (0)
Institutions that held Psyence Biomedical Ltd. at the end of Q1 2026 and filed for Q2 2026 without it.
None.